A technology-led, purpose driven oncology platform, enabling discovery through delivery of care
Successful integration of approaches from mathematics, physics, and engineering with cancer biology may be our best hope to understand complex systems of cancer and to develop effective strategies for cancer treatment.
Reliance Digital Health Ltd, the wholly owned subsidiary of Reliance Industries Limited, has acquired a minority stake in Karkinos Healthcare.
Karkinos has chosen openEHR standard for building an oncology-focused technology platform.
Getting a second opinion helps to recognize available choices and make an educated decision on what is right for the patient. Given this veracity, variety and ever evolving treatment options, patients have the right to ask for a second opinion from experts.
Karkinos Healthcare has laid down its primary goal to shift the focus of cancer care towards the left side of the spectrum, i.e., early detection and infuse a behavioral shift among citizens in their attitude from illness to wellness.
Karkinos Healthcare closed a funding round with the Tatas Group drawing an investment of Rs 110 crores. Tata Group has disbursed Rs. 35 crores immediately and the rest of the funding is expected to be disbursed in tranches in the coming months.
By Dr. Moni Abraham Kuriakose – Medical Director, Karkinos Healthcare & CEO, Karkinos Healthcare, Kerala
The core objective of Karkinos Healthcare is to create an up-to-date dynamic knowledge base and curate that knowledge to distribute, democratize, and integrate…
Karkinos Healthcare (KH) desires to build an end-to-end technology driven oncology focused managed healthcare platform where almost no person is deprived of care either by lack of access or affordability.